Patients with NSCLC harboring um-EGFRm had a poorer response, lower ORR and shorter PFS than those of patients with 19del/L858R after receiving first-generation EGFR-TKIs (13, 15, 19). Here, EGFR is linked to non-small cell lung carcinoma.